HealthcareServices

Allergy Immunotherapy Market Report 2026: Strategic Insights and Revenue Outlook

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the allergy immunotherapy market from 2026–2035 with trusted insights from The Business Research Company

How is the Allergy Immunotherapy Market size predicted to change over the forecast window of 2026–2035?

The allergy immunotherapy market has seen rapid expansion in recent years. Its size is expected to increase from $3.16 billion in 2025 to $3.55 billion in 2026, registering a compound annual growth rate (CAGR) of 12.3%. This historical growth can be attributed to several factors including limited awareness about allergy immunotherapy, rising incidence of seasonal allergic rhinitis, dependency on hospital-based treatment channels, adoption of traditional treatment methods, and regulatory approvals for immunotherapy products.

The allergy immunotherapy market is projected to experience substantial expansion in the coming years. It is anticipated to grow to **$5.64 billion** by 2030, exhibiting a compound annual growth rate (CAGR) of **12.2%**. This projected growth during the forecast period can be attributed to the rise in personalized immunotherapy solutions, increasing adoption of online pharmacy channels, the expansion of pediatric allergy treatment, growing investment in immunotherapy research, and the development of combination immunotherapy products. Significant trends for the forecast period include the increasing acceptance of subcutaneous and sublingual immunotherapy, the rising prevalence of allergic rhinitis and asthma, the broadening of food and venom allergy treatments, a heightened focus on personalized allergy treatment protocols, and improved awareness leading to earlier diagnosis of allergic conditions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Which Drivers Are Contributing To The Expansion Of The Allergy Immunotherapy Market?

The increasing occurrence of allergic disorders is anticipated to drive the future expansion of the allergy immunotherapy market. Allergic disorders are characterized by excessive immune responses to specific antigens, distinct from autoimmune diseases where immune responses are misdirected against the body’s own components. Allergy immunotherapy is administered to atopic individuals suffering from allergic conditions such as IgE-mediated allergic rhinitis and allergic asthma, which are triggered by inhaled allergens like pollens and house dust mites (HDMs). For instance, in August 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK executive agency, reported that English hospitals recorded over 25,000 admissions for allergies and anaphylaxis during 2022-23, a figure more than double that observed in the last twenty years. Additionally, in May 2024, the UK’s Food Standards Agency published its Patterns and Prevalence of Adult Food Allergy (PAFA) report, revealing that approximately 6% of adults in the UK, equating to around 2.4 million individuals, are affected by food allergies. As a result, the rising prevalence of allergic disorders is significantly contributing to the growth of the allergy immunotherapy market.

What Segment Classifications Make Up The Allergy Immunotherapy Market?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Allergic Asthma: House Dust Mite–Induced Allergic Asthma, Pollen-Induced Allergic Asthma, Animal Dander–Induced Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Bee Venom Allergy, Wasp Venom Allergy, Hornet Venom Allergy, Other Insect Venom Allergies

5) By Allergic Conjunctivitis: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis

6) By Environmental Allergies: House Dust Mite Allergy, Pollen Allergy, Mold Allergy, Animal Dander Allergy

Which Market Trends Are Opening Growth Opportunities In The Allergy Immunotherapy Market?

Major companies within the allergy immunotherapy market are developing innovative technological products, such as artificial intelligence (AI)-powered allergy component testing, to maintain their market position. This AI-powered allergy component testing is a novel diagnostic platform based on component resolved diagnostics (CRD) for identifying various types of allergies. As an illustration, in May 2023, Metropolis Healthcare Limited, an Indian medical laboratory company, launched its artificial intelligence (AI)-powered allergy component testing. This technology is recognized as a fourth-generation allergy testing solution that utilizes Artificial Intelligence (AI) to support clinicians in their clinical decision-making. It offers significant insights for selecting and optimizing treatment plans for allergic diseases, and it can also predict the effectiveness of immunotherapy for allergy vaccinations.

Which Key Players Are Driving Competition In The Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Mylan N.V., Adamis Pharmaceuticals Corporation, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Region Is Projected To Lead The Allergy Immunotherapy Market During The Forecast Period?

Europe was the largest region in the allergy immunotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Allergy Immunotherapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

Browse Through More Reports Similar to the Global Allergy Immunotherapy Market 2026, By The Business Research Company

Cellulars Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Allergy Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Allergy Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795